| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
674,040,000 |
| Market
Cap: |
14.92(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$17.15 - $26.07 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
27,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
27,872 |
60,449 |
104,821 |
| Total Sell Value |
$0 |
$687,456 |
$1,380,595 |
$2,464,073 |
| Total People Sold |
0 |
3 |
4 |
5 |
| Total Sell Transactions |
0 |
4 |
6 |
13 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-24 |
4 |
S |
$31.75 |
$289,687 |
D/D |
(9,124) |
139,095 |
|
-32% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-24 |
4 |
OE |
$17.67 |
$161,221 |
D/D |
9,124 |
148,219 |
|
- |
|
| Wondrasch Michael |
EVP & CIO |
• – – |
2021-05-21 |
4 |
S |
$31.41 |
$580,708 |
D/D |
(18,488) |
113,295 |
|
-31% |
|
| Miller Justin |
EVP & General Counsel |
• – – |
2021-05-20 |
4 |
AS |
$31.12 |
$575,347 |
D/D |
(18,488) |
86,536 |
|
31% |
|
| Couturier Christophe |
EVP, AMEA |
• – – |
2021-05-20 |
4 |
AS |
$31.13 |
$778,561 |
D/D |
(25,010) |
138,173 |
|
31% |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2021-05-20 |
4 |
AS |
$31.10 |
$609,653 |
D/D |
(19,603) |
149,379 |
|
31% |
|
| Wondrasch Michael |
EVP & CIO |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$421,940 |
D/D |
(13,655) |
131,783 |
|
- |
|
| Stubblefield Michael |
President and CEO |
• • – |
2021-05-17 |
4 |
D |
$30.90 |
$3,281,580 |
D/D |
(106,200) |
1,403,281 |
|
- |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$608,205 |
D/D |
(19,683) |
168,982 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$518,904 |
D/D |
(16,793) |
139,095 |
|
- |
|
| Couturier Christophe |
EVP, AMEA |
• – – |
2021-05-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,276) |
163,183 |
|
- |
|
| Vanderhaegen Frederic |
EVP, Europe |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$68,289 |
D/D |
(2,210) |
214,384 |
|
- |
|
| Bramwell James |
EVP, Strategic Partners |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$442,612 |
D/D |
(14,324) |
103,812 |
|
- |
|
| Eck Steven W |
SVP & Chief Accounting Officer |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$17,088 |
D/D |
(553) |
31,531 |
|
- |
|
| Miller Justin |
EVP & General Counsel |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$421,940 |
D/D |
(13,655) |
105,024 |
|
- |
|
| Szlosek Thomas A |
EVP & CFO |
• – – |
2021-05-17 |
4 |
D |
$30.90 |
$718,765 |
D/D |
(23,261) |
249,394 |
|
- |
|
| Kang Lan |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,022 |
4,022 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-14 |
4 |
D |
$31.50 |
$787,500 |
D/D |
(25,000) |
155,888 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-05-14 |
4 |
OE |
$23.21 |
$580,250 |
D/D |
25,000 |
180,888 |
|
- |
|
| Natauri Jo |
Director |
– • – |
2021-05-11 |
4 |
A |
$30.86 |
$2,859,518 |
D/D |
92,661 |
92,661 |
|
- |
|
| Natauri Jo |
Director |
– • – |
2021-05-11 |
4 |
D |
$30.86 |
$763,152,216 |
I/I |
(24,729,495) |
175,625 |
|
- |
|
| Natauri Jo |
Director |
– • – |
2021-05-11 |
4 |
S |
$30.68 |
$80,589,334 |
I/I |
(2,626,771) |
24,807,518 |
|
-38% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-04-30 |
4 |
S |
$32.58 |
$1,747,884 |
D/D |
(53,649) |
155,888 |
|
-31% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2021-04-30 |
4 |
OE |
$23.21 |
$1,245,193 |
D/D |
53,649 |
209,537 |
|
- |
|
| Bramwell James |
EVP, Strategic Partners |
• – – |
2021-04-12 |
4 |
AS |
$32.00 |
$80,160 |
D/D |
(2,505) |
118,136 |
|
18% |
|
534 Records found
|
|
Page 11 of 22 |
|
|
0.21 (0.94%) 
